ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling

Xie, Chun-Feng; Feng, Kun-Liang; Wang, Ji-Nan; Luo, Rui; Fang, Chong-Kai; Zhang, Ying; Shen, Chuang-Peng*; Zhong, Chong*广州中医药大学; 1
Journal of Ethnopharmacology2022-8-10DOI: 10.1016/j.jep.2022.115360
4被引6阅读
引用收藏
分享

摘要

Ethnopharmacological relevance: Jianpi Huayu decoction (JHD) is a traditional Chinese medicinal preparation used to treat a variety of malignant tumors including HCC, although the underlying mechanism remains unknown. Exosomes in the tumor microenvironment mediate intercellular signaling among cancer cells, but precise contributions to hepatocellular carcinoma (HCC) progression are still elusive. Aim of the study: In this work, the main objective was to examine the mechanisms underlying anti-tumor effects of JHD and the potential contributions of exosomal signaling. Materials and methods: LC-MS/MS was used for quality control of JDH preparation, while nanoparticle tracking analysis (NTA), transmission electron microscopy (TEM) and western blotting were used for verification of exosomes. In vitro assays included CCK8, wound healing assay, transwell invasion assay, qRT-PCR and western blotting were performed to investigate the effects of JHD on HCC cells and the molecular mechanism. Furthermore, the effects of JHD on subcutaneous tumor model of nude mice were also determined. Results: JHD inhibited the proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) of cultured HCC cells. Further, exosomes isolated from EMT-induced HCC cells promoted the migration, invasion and EMT of other cultured HCC cells, while exosomes isolated from EMT-induced HCC cells after JHD treatment had little effect. In addition, JHD reduced the expression of exosomal miR-23a-3p in cultured HCC cells. miR23a-3p was significantly up-regulated in tumor compared with that in adjacent non-cancerous tissues of patients with HCC. HCC patients with high miR-23a-3p expression had poor overall survival after hepatectomy. Meanwhile, miR-23a-3p enhanced HCC cell proliferation, EMT, and expression of Smad signaling proteins. More importantly, overexpression of miR-23a-3p can reverse the inhibition of EMT and Smad signaling pathway caused by JHD treatment. In vivo assays, treatment with JHD also reduced the growth of HCC-derived tumors in nude mice, reduced the expression of miR-23a-3p in serum exosomes and the level of EMT in tumor cells. Conclusions: the antitumor effects of JHD on HCC are mediated at least in part by inhibition of EMT due to downregulation of exosome-mediated intercellular miR-23a-3p transfer and subsequent blockade of Smad signaling. Disrupting this exosomal miR-23a-3p/Smad signaling pathway may be an effective treatment.

学科与关键词

关键词
Hepatocellular carcinomaJianpi huayu decoctionExosomemiR-23a-3pEpithelial mesenchymal transition
相关
加载中…
  • JPHYD Inhibits miR-21-5p/Smad7-Mediated Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells
    Liu, Li-Hua; Fang, Chong-Kai; Ge, Fu-Cheng; Wang, Ji-Nan; Zhang, Xiu-Bing; Luo, Rui; Zhang, Ying; Feng, Kun-Liang; Qiu, Zhen-Wen*; Zhong, Chong*Journal of Oncology, 2022, 2022: 7823433.被引 6
  • Jianpi-Huayu Formula Inhibits Development of Hepatocellular Carcinoma by Regulating Expression of miR-602, Which Targets the RASSF1A Gene
    Huang, Yajing; Zhou, Cheng; Wen, Huihong; Chen, Yongxu; Xie, Yingjie; Lan, Xiaohe; Lin, Juze; Huang, Xuhui; Mo, Yousheng; Yang, Cong; Wang, Qi; Wang, Changjun*INTEGRATIVE CANCER THERAPIES, 2020, 19: 1534735419900804.被引 4
  • Biejiajian Pill Inhibits Carcinogenesis and Metastasis via the Akt/GSK-3β/Snail Signaling Pathway in Hepatocellular Carcinoma
    Sun, Jialing; Chen, Weicong; Wen, Bin; Zhang, Mingjia; Sun, Haitao; Yang, Xuemei; Zhao, Wenting; La, Lei; An, Haiyan; Pang, Jie; Gao, Lei*; He, Songqi*Frontiers in Pharmacology, 2021, 12: 610158.被引 8
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Ethnopharmacology
发表日期
2022-08-10
卷期
第 294 卷
页码
115360
DOI
10.1016/j.jep.2022.115360
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81873303]; Natural Science Foundation of Guangdong Province, China [2019A1515011013]; Key Projects of Educational Commission of Guangdong Province, China [2019KZDXM045]; Medical innovation project of the First Affiliated Hospital of Guangzhou University of Chinese Medicine [2019IIT18]; Administration of Traditional Chinese Medicine of Guangdong Province, China [20211122]; Science and Technology Planning Project of Guangzhou [202102010406]

作者

  • X

    Xie, Chun-Feng (第一作者)

    liuzhou tradit chinese med hosp · 1 · guangzhou univ chinese med

  • F

    Feng, Kun-Liang

    1 · guangzhou univ chinese med

查看全部 8 位作者收起作者
  • W

    Wang, Ji-Nan

    1 · guangzhou univ chinese med

  • L

    Luo, Rui

    1 · guangzhou univ chinese med

  • F

    Fang, Chong-Kai

    1 · guangzhou univ chinese med

  • Z

    Zhang, Ying

    1 · guangzhou univ chinese med

  • S

    Shen, Chuang-Peng (通讯)

    1 · guangzhou univ chinese med

  • Z

    Zhong, Chong (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417